Feed/Companies/Acta Pharmaceuticals

Acta Pharmaceuticals

As of 16 Oct 2026, Acta Pharmaceuticals has raised $24M across 1 verified round on record; latest: $24 million seed round, announced 15 Oct 2026.

A provider of therapies designed for early intervention and prevention in Alzheimer’s disease

LATEST ROUND

Seed

$24M · 2026-10-15

RAISED ON RECORD · USD

$24M

across 1 verified round

ROUNDS ON RECORD

1 published

SOURCES

from 6 publishers

Company

Every round on record, with the sources behind each and the investors on them.

Seed

$24M · 2026-10-15

lead not stated

Round	Amount	Announced	Lead	Buzz
Seed	$24M $24M total raised	2026-10-15	not stated	6 outlets. #67 in Trending
6 sources [ VERIFIED · CORRECTED ] read against 4 of 6 sources Removed Alzheimer’s Disease Research Foundation, Dolby Family Ventures, Gamma Bio Investors · not in this round The sources name shareholders but do not identify them as investors in this financing; no lead or participating investors are stated.